---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-029232"
form_type: "8-K"
ticker: "ZLAB"
cik: "0001704292"
company_name: "Zai Lab Ltd"
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T01:33:23.833612+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Zai Lab Q3 revenue $57.5M (+33% YoY); net loss widens to $161.2M on Seagen payment

## Summary
- Total revenues $57.5M vs $43.1M YoY; net product revenue led by ZEJULA $39.2M.
- Net loss $161.2M vs $96.4M YoY, reflecting $30M upfront to Seagen and $36.7M FX loss.
- Cash & equivalents $1.12B; company expects runway through 2025.
- Entered collaboration with Seagen for TIVDAK in Greater China.
- Appointed Dr. Peter Huang as CSO and Alette Verbeek as SVP Global Strategic Partnering.

## SEC filing metadata
- accession: 0001628280-22-029232
- form_type: 8-K
- ticker: ZLAB
- cik: 0001704292
- company_name: Zai Lab Ltd
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704292/000162828022029232/0001628280-22-029232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704292/000162828022029232/zlab-20221109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-029232
- JSON: https://secwatch.observer/filing/0001628280-22-029232.json
- Plain text: https://secwatch.observer/filing/0001628280-22-029232.txt

## Key facts
- Earnings Releases
  Zai Lab Ltd reported the three months ended September 30, 2022 results: revenue $57.5 million.
  - Period: the three months ended September 30, 2022
  - Revenue: $57.5 million
  - Result: reported results
  source text: expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Zai Lab Announces Third Quarter 2022 Financial Results and Corporate Updates – Revenue of $57.5 million for the third quarter of 2022, representing a 33% increase y-o-y and a 19% increase q-o-q; continued revenue growth led by ZEJULA – Regional strategic collaboration for TIVDAK ®
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704292/000162828022029232/0001628280-22-029232-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.